biosimilars

Don't give up yet on biosimilars, Gottlieb says. Congress could give them a boost
Fierce Pharma
Tue, 08/27/19 - 10:59 am
biosimilars
congress
Scott Gottlieb
Amgen, Allergan biosimilar of Roche's blockbuster Rituxan clears another US pivotal study
Endpoints
Thu, 08/22/19 - 11:54 am
Novartis
Amgen
Allergan
biosimilars
Roches
Rituxan
ABP 798
Lilly faces biosimilar rivals to osteoporosis drug Forsteo in Europe
Pharmaforum
Wed, 08/21/19 - 10:37 am
Eli Lilly
biosimilars
osteoporosis
Forsteo
Europe
Stada
Gedeon Richter
Amgen biosimilar debut boosted by UnitedHealthcare coverage switch
Biopharma Dive
Mon, 08/19/19 - 11:52 am
insurers
Amgen
biosimilars
Avastin
Herceptin
Roche
UnitedHealthcare
Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi
Pharmaceutical Business Review
Wed, 08/14/19 - 11:13 am
Novartis
Sandoz
biosimilars
Amgen
Enbrel
patents
Erelzi
FTC investigates J&J contracts regarding the drugmaker's blockbuster Remicade
Endpoints
Tue, 07/30/19 - 07:59 am
FTC
JNJ
Remicade
antitrust
biosimilars
Pfizer
Inflectra
AbbVie's psoriasis launch Skyrizi hitting stride ahead of FDA's decision on upadacitinib
Fierce Pharma
Fri, 07/26/19 - 12:07 pm
AbbVie
Humira
biosimilars
Europe
psoriasis
rheumatoid arthritis
Skyrizi
FDA-approved Humira copycat from Merck, Samsung Bioepis will wait 4 years to launch
Endpoints
Wed, 07/24/19 - 10:07 am
Merck
Samsung Bioepis
FDA
Humira
AbbVie
drug launches
biosimilars
FDA approves Rituxan biosimilar
Beckers Hospital Review
Tue, 07/23/19 - 07:40 pm
Pfizer
biosimilars
FDA
Ruxience
cancer
autoimmune disease
Genentech
Merck's biosimilar to AbbVie's Humira wins FDA approval
Reuters
Tue, 07/23/19 - 07:35 pm
Merck
Hadlima
biosimilars
FDA
AbbVie
Humira
Sandoz recruits first patient in clinical study for proposed biosimilar denosumab in osteoporosis
Pharmaceutical Business Review
Tue, 07/23/19 - 10:03 am
Novartis
Sandoz
biosimilars
clinical trials
denosumab
osteoporosis
Prolia
Xgeva
Roche doomsday is here: Long-feared Herceptin, Avastin biosims bust into U.S. market
Fierce Pharma
Fri, 07/19/19 - 07:28 pm
Herceptin
Avastin
Roche
biosimilars
Allergan
Amgen
Pfizer's keys to juggling 8 U.S. launches? Organization, accountability, clear goals
Fierce Pharma
Fri, 07/19/19 - 01:19 pm
Pfizer
oncology
drug launches
biosimilars
J&J warns generics will bite its pharma unit in the second half
Pharmaforum
Wed, 07/17/19 - 09:49 am
JNJ
generics
biosimilars
Darzalex
Zytiga
Biosimilars Continue To Exhibit Market Failure
Forbes
Thu, 07/11/19 - 11:59 am
biosimilars
Why AbbVie's Stock Sank in the First Half of 2019
Motley Fool
Fri, 07/5/19 - 01:51 pm
AbbVie
Humira
biosimilars
M&A
Allergan
Another Biosimilar Approval From FDA, Another Unknown Launch Date
RAPS.org
Fri, 06/28/19 - 12:31 pm
Pfizer
Zirabev
biosimilars
FDA
Roche
cancer
Avastin
Samsung Bioepis CEO urges patience as US biosimilar market lags
BioPharma Dive
Wed, 06/26/19 - 12:04 pm
biosimilars
Samsung Bioepis
FDA Approves 20th Biosimilar, 5th for Roche’s Herceptin
RAPS.org
Thu, 06/13/19 - 10:37 pm
FDA
biosimilars
Roche
Herceptin
Amgen
Kanjinti
Iranian drugmaker opens $100M plant in Turkey, will make Humira biosimilar
Fierce Pharma
Thu, 06/13/19 - 09:50 pm
Turkey
Iran
Humira
biosimilars
CinnaGen Pharmaceuticals

Pages